Oral trimethoprim: A relatively safe and successful third-line treatment for acne vulgaris

British Journal of Dermatology

Volumn 141, Issue 4, 1999, Pages 757-758

  Cunliffe, W J ^a   Aldana, O L ^a   Goulden, V ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI ACNE AGENT; BENZAMYCIN; BENZOYL PEROXIDE; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; MINOCYCLINE; OXYTETRACYCLINE; RETINOID; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ACNE VULGARIS; ADULT; ANTIBIOTIC THERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; VAGINA CANDIDIASIS;

ACNE VULGARIS; ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; TRIMETHOPRIM;

EID: 0032717326     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.03132.x     Document Type: Letter

References (13)

1. Cunliffe WJ, van de Kerkhof PCM, Caputo R et al. Roaccutane treatment guidelines: results of an international survey. Dermatology 1997; 194: 351-7.
2. Eady EA, Jones CE, Tipper JL et al. Antibiotic resistant propioni-bacteria in acne: need for policies to modify antibiotic usage. Br Med J 1993; 306: 555-6.
3. Dréno B, Lagallou F, de Saint Marie I, Rihet HK. Prevalence of erythromycin resistant propionibacteria and Staphylococcus epi-dermidis in acne patients in France. J Invest Dermatol 1997; 108: 379 (Abstr.).
4. Meacock DJ, Hewer RL. Tetracycline and benign intracranial hypertension. Br Med J 1981; 282: 1240.
5. Okada N, Moriya K, Hishida K et al. Skin pigmentation associated with minocycline therapy. Br J Dermatol 1989; 121: 247-54.
6. Gough A, Chapman S, Wagstaff K et al. Minocycline induced autoimmune hepatitis and systemic lupus erythematosus like syndrome. Br Med J 1996; 312: 169-72.
7. Knowles SR, Shapiro L, Shear NH. Serious adverse reactions induced by minocycline. Arch Dermatol 1996; 132: 934-9.
8. Gibson JR, Darley CR, Harvey SG et al. Oral trimethoprim versus oxytetracycline in the treatment of inflammatory acne vulgaris. Br J Dermatol 1982; 107: 221-4.
9. Bottomley WW, Cunliffe WJ. Oral trimethoprim as a third line antibiotic in the management of acne vulgaris. Dermatology 1993; 187: 193-6.
10. Burke BM, Cunliffe WJ. The assessment of acne vulgaris-the Leeds technique. Br J Dermatol 1984; 111: 83-92.
11. Layton AM, Hughes BR, MacDonald Hull S et al. Seborrhoea-an indicator for poor clinical response in acne patients treated with antibiotics. Clin Exp Dermatol 1992; 17: 173-5.
12. Jick H, Derby LE. Is co-trimoxazole safe? Lancet 1991; 345: 1118-19.
13. Brumfitt W, Hamilton-Miller JMT. Trimethoprim. Br J Hosp Med 1980; 23: 281-8.